Patent Yard Sign in
Canadian application, no grantCanada

Methods for stimulating nervous system regeneration and repair by inhibition phosphodiesterase type 4

CA 2427430 A1 · Owner: Filbin, Marie T. · Inventors: Nikulina, Elena; Filbin, Marie T.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to the novel identification of inhibitors of phosphodiesterase type 4 ("PDE4") as agents which can reverse inhibition of neural regeneration in the mammalian central and peripheral nervous system. The invention provides compositions and methods using agents that can reverse the inhibitory effects on neural regeneration by regulating PDE4 expression. A composition compressing at least one PDE4 inhibitor in an amount effective to inhibit PDE4 activity in a neuron when administered to an animal is provided. Methods for regulating (e.g. promoting) neural growth or regeneration in the nervous system, methods for treating injuries or damage to nervous tissue or …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 2, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 2, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 2, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 2, 2001
GrantedNo grant recorded
Term endedNovember 2, 2021
Patent numberCA 2427430 A1
Classification (IPC)A61K45/06 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedNov 2, 2001Term endedNov 2, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.